| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 11/02/1989 | EP0340153A1 N-substituted imidazoles, process for their preparation and their use in medicaments |
| 10/31/1989 | US4877791 Method of treatment for interestitial cystitis |
| 10/25/1989 | EP0338395A2 Monoclonal antibodies to Pseudomonas aeruginosa, their production and use |
| 10/19/1989 | WO1989009936A1 Isoferritin as a marker for pathological pregnancy |
| 10/19/1989 | WO1989009773A1 (d)-6-FLUORO-2,3-DIHYDRO-2',5'-DIOXO-SPIRO[4H-1-BENZOPYRAN-4,4'-IMIDAZOLIDINE]-2-CARBOXAMIDE DERIVATIVES, MANUFACTURING PROCESS AND USE THEREOF |
| 10/18/1989 | EP0337929A1 N-substituted imidazoles, process for their preparation and their pharmaceutical application |
| 10/18/1989 | EP0337928A1 N-substituted imidazoles, process for their preparation and their pharmaceutical application |
| 10/18/1989 | EP0337420A2 Antimicrobial dialysis and rinsing liquid for intraperitoneal delivery |
| 10/17/1989 | US4874898 Antiandrogens |
| 10/11/1989 | EP0336416A1 (d)-6-Fluoro-2,3-dihydro-2',5'-dioxo-spiro[1H-1-Benzopyran-4,4'-imidazolidine]-2-carboxamide derivatives, process for the preparation and use of the derivatives |
| 10/10/1989 | US4873223 Treating male infertility |
| 10/05/1989 | DE3909707A1 Arzneimittel, geeignet zur einwirkung auf herz und kreislauf Medicines suitable for acting on heart and circulatory system |
| 10/04/1989 | CN1036011A Modulation drug contg. acetylate benzilic acid derivs. for urocyst-tonus, special acctylate benzilic acid derivs. and use thereof |
| 10/03/1989 | US4871771 Phenyl substituted-dithia-alkanedioic acids |
| 10/03/1989 | US4871670 Dna transfer vector |
| 10/03/1989 | US4871543 Controlled release of 17-beta-estradiol from elastomer core of ring |
| 09/28/1989 | DE3809031A1 Neues mittel gegen obstruktive blasenentleerungsstoerung New medium against obstructive blasenentleerungsstoerung |
| 09/27/1989 | EP0334425A1 Novel delta4 - androstene derivatives |
| 09/27/1989 | EP0333769A1 Combinations of renal vasodilators and alpha 1-adrenergic or ganglionic blocking agents for treating diseases |
| 09/26/1989 | US4870067 Oxytocins and antigestagens in combination for induction of birth |
| 09/26/1989 | CA1261849A1 L-lysine pyruvate and l-histidine pyruvate |
| 09/26/1989 | CA1261755A1 Alfuzosine compositions and use |
| 09/26/1989 | CA1261262A1 Method of inducing labour or terminating a pregnancy using a prostaglandin and an antigestagen and packs and preparations suitable therefor |
| 09/21/1989 | WO1989008653A1 1H/3H-[4-(N,N-DICYCLOALKYL/BRANCHED-ALKYLCARBOXAMIDO)-BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS |
| 09/21/1989 | WO1989008454A1 Fluorobenzoylpiperidinopropoxymethoxyphenylpyrrolidone effective against obstructive difficulties in urinating |
| 09/20/1989 | EP0333676A2 Use of 1-(2-ethoxy-2-(3'-pyridyl)ethyl)-4-(2'methoxy-phenyl)piperazine, for the preparation of pharmaceutical compositions useful for the treatment of lower urinary tract disfunctions and benign prostatic hypertrophy |
| 09/20/1989 | CN1035619A Human relaxin formulation |
| 09/19/1989 | US4868212 Pharmaceutical and dietary composition |
| 09/12/1989 | US4866063 Diuretics; hypotensive agents; antiedemic agents; lowered cardiotoxic side effect |
| 09/12/1989 | US4866047 Method for inhibiting the formation of urinary calculus utilizing 24,25-(OH)2 -D3 |
| 09/08/1989 | WO1989007945A1 Human relaxin formulation |
| 09/06/1989 | EP0330786A1 Topical drug delivery systems containing danazol |
| 09/05/1989 | US4863911 Method for treating male sexual dysfunction |
| 08/30/1989 | CN1035116A Heterocyclic oxophthalazinyl acetic acids |
| 08/24/1989 | WO1989007451A1 Reduced size lhrh analogs |
| 08/16/1989 | EP0328255A1 A medicament for the treatment of a fibrotic disorder, and anti-fibrotic composition |
| 08/16/1989 | EP0328089A2 Reduced size LHRH analogs |
| 08/16/1989 | EP0327612A1 Pharmaceutical therapeutic use of glutathione derivatives |
| 08/10/1989 | WO1989007105A1 Staurosporin derivatives |
| 08/09/1989 | EP0327503A1 Use of IGF I in the manufacture of a medicament for the treatment of renal diseases |
| 08/09/1989 | EP0327306A2 Leukotriene B4 antagonists |
| 08/08/1989 | US4855136 Therapeutic composition and method |
| 08/02/1989 | EP0326297A1 Thioformamide derivatives |
| 07/27/1989 | WO1989006651A1 1h-indazole-3-acetic acids as aldose reductase inhibitors |
| 07/26/1989 | EP0325375A1 1H-indazole-3-acetic acids as aldose reductase inhibitors |
| 07/26/1989 | EP0325187A1 4-alkyl-1, 4-dihydropyridines with PAF-antagonist activity |
| 07/25/1989 | US4851413 Certain benzoquinones, naphthoquinones, corresponding hydroquinones which exhibit thromboxane A2 synthetase inhibition or receptor antagonism and the like |
| 07/25/1989 | US4851408 Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazol[5,4-d]azepine for releasing growth hormone |
| 07/25/1989 | US4851386 Method of treating precocious puberty |
| 07/19/1989 | EP0324377A2 Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids |
| 07/18/1989 | US4849452 L-cysteine or salts, kidney stones |
| 07/13/1989 | WO1989006233A1 Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| 07/11/1989 | US4847363 Electrophoresis |
| 07/11/1989 | US4847299 Bone disorders |
| 07/04/1989 | US4845104 Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones |
| 06/29/1989 | WO1989005857A1 A METHOD OF SIMULTANEOUSLY PRODUCING A LARGE NUMBER OF Leu17-VIP-ANALOGS AND NEW Leu17-VIP-ANALOGS |
| 06/29/1989 | WO1989005793A1 N-acyl-n-naphthoylglycines as aldose reductase inhibitors |
| 06/29/1989 | WO1989005791A1 N-naphthoylglycines as aldose reductase inhibitors |
| 06/29/1989 | WO1989005660A1 Pharmaceutical preparation for individual prophylaxis of venereal diseases and curing urogenital trichomoniasis |
| 06/28/1989 | EP0322352A2 Use of anti-progestins for preparation of medicaments |
| 06/28/1989 | EP0322256A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors |
| 06/28/1989 | EP0322255A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors |
| 06/28/1989 | EP0322153A2 Heterocyclic oxophtalazinyl acetic acids |
| 06/21/1989 | EP0321274A1 Derivatives of thioformamide |
| 06/21/1989 | EP0321273A2 Thioformamide derivatives |
| 06/21/1989 | EP0320935A2 Method of preventing or treating toxemia in pregnancy using a thromboxane A2 receptor antagonist |
| 06/21/1989 | EP0320805A2 Acylated benzilic acid derivatives for the regulation of the tonus of the urinary bladder |
| 06/20/1989 | US4840970 Aqueous solution containing lipid-soluble pharmaceutical substance |
| 06/20/1989 | US4840896 Human fertility hormones rna encoding by vectors |
| 06/20/1989 | CA1256031A1 Pharmaceutical compositions containing diltiazem and alfuzosin |
| 06/14/1989 | EP0319947A2 Bis-S-alkylbenzene derivatives |
| 06/07/1989 | EP0318490A1 14,17-g(b)-ETHANO-14-g(b)-ESTRATRIENES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE. |
| 05/31/1989 | EP0318377A2 Enantiomeric derivatives of amino acids, process for their preparation and their pharmaceutical applications |
| 05/24/1989 | EP0316993A1 Pharmaceutical compositions containing a derivative of 3-hydroxy-butanoic acid chosen among oligomers of this acid and among esters of this acid or of these oligomers with 1,3-butane-diol |
| 05/24/1989 | EP0316907A2 Enzyme inhibitor and method of producing the same |
| 05/23/1989 | CA1254559A1 Class of spiro-linked pyrrolidine-2,5-diones and preparations thereof |
| 05/18/1989 | WO1989004324A1 Phosphoryled derivatives of cardiodilatine/anf peptides |
| 05/18/1989 | DE3737917A1 Phosphorylierte derivate von cardiodilatin/anf-peptiden Phosphorylated derivatives of cardiodilatin / anf-peptides |
| 05/16/1989 | US4831043 Dopaminergic benzimidazol-2-ones |
| 05/10/1989 | EP0314863A2 Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation |
| 05/09/1989 | US4829067 Inhibitors of reflective contraction of bladder |
| 05/02/1989 | US4826877 Polyunsaturated acids to treat diabetic neuropathy |
| 05/02/1989 | CA1253520A1 N-(6-methoxy-5 (perfluoroalkyl)-1-naphthoyl)-n- methylglycines and their thionaphthoyl analogs |
| 04/20/1989 | WO1989003393A1 Vasoactive peptides |
| 04/11/1989 | US4820870 Acidic alkali citrate and compositions for adjusting the ph of urine |
| 04/11/1989 | US4820727 Treating diabetic complications-vision defects, kidney and nervous system disorders |
| 04/11/1989 | CA1252470A1 Tetrahydropyridines, process for their preparation and their use in medicaments |
| 04/05/1989 | EP0310541A1 Antigestagenic and antioestrogenic compounds for the introduction of labour and interruption of pregnancy, as well as for the treatment of gynecologic disorders |
| 04/05/1989 | EP0309863A2 Composition and method to release an immune reaction to GnRH and method for the immunosterilization of mammals |
| 04/04/1989 | CA1252085A1 Steroidic aromatase inhibitors |
| 03/30/1989 | DE3830563A1 Orale magnesium und kalium enthaltende praeparate und deren verwendung Oral magnesium and potassium-containing preparations and their use |
| 03/29/1989 | EP0309424A2 New amidino derivatives |
| 03/29/1989 | EP0309422A2 New amidino tricycle derivatives |
| 03/29/1989 | CN1032031A Nf-1616-904 oxide of pyrazine and medicine composition contained this compound |
| 03/21/1989 | US4814327 Antiprogesterone, antiglucocorticord |
| 03/09/1989 | WO1989001934A1 Hydantoin derivatives |
| 03/08/1989 | EP0305947A1 Hydantoin derivatives, process for their preparation and pharmaceutical compositions containing the same as well as their use |
| 03/01/1989 | CN1031376A Pyrazolopyridine compound andprocesses for preparation thereof |
| 02/28/1989 | US4808710 18-Phenyloestrane derivatives |
| 02/28/1989 | US4808627 Method of preventing or treating toxemia in pregnancy using a thromboxane A2 receptor antagonist |